As of Jul 02
| -0.17 / -3.45%|
The 6 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 10.50, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +120.59% increase from the last price of 4.76.
The current consensus among 7 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.